- Home
- ZDAI vs HIND Comparison
ZDAI vs HIND Comparison
Compare ZDAI & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZDAI | HIND |
|---|---|---|
| Founded | 2022 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | 2 |
| Industry | General Bldg Contractors - Nonresidential Bldgs | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6M | 15.2M |
| IPO Year | 2023 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ZDAI | HIND |
|---|---|---|
| Price | $1.64 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 47.3K | 7.4K |
| Earning Date | 05-15-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $319,714.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 24.43 |
| 52 Week Low | $0.20 | $1.75 |
| 52 Week High | $11.48 | $9.69 |
Technical Indicators
Market Signals| Indicator | ZDAI | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 46.22 |
| Support Level | $1.62 | $1.99 |
| Resistance Level | $2.04 | $2.35 |
| Average True Range (ATR) | 0.17 | 0.11 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 13.00 | 46.03 |
Price Performance
Historical ComparisonAbout ZDAI Primega Group Holdings Limited Ordinary Shares
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.